4-hydroxymephenytoin has been researched along with pantoprazole in 1 studies
Studies (4-hydroxymephenytoin) | Trials (4-hydroxymephenytoin) | Recent Studies (post-2010) (4-hydroxymephenytoin) | Studies (pantoprazole) | Trials (pantoprazole) | Recent Studies (post-2010) (pantoprazole) |
---|---|---|---|---|---|
36 | 5 | 0 | 1,467 | 476 | 579 |
Protein | Taxonomy | 4-hydroxymephenytoin (IC50) | pantoprazole (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 1.5 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.8 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 7.75 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hakusui, H; Ishizaki, T; Kaneko, S; Ohkubo, T; Otani, K; Ryokawa, Y; Sugawara, K; Suzuki, A; Tanaka, M; Yamamori, S | 1 |
1 other study(ies) available for 4-hydroxymephenytoin and pantoprazole
Article | Year |
---|---|
Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Half-Life; Humans; Japan; Male; Mephenytoin; Metabolic Clearance Rate; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides | 1997 |